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Overview of Thesis 
 
This thesis follows the portfolio format and the following information provides a 
brief summary of the main chapters of the thesis: 
 
Chapter 1 is a systematic review of the research literature regarding the impact of 
anxiety upon hospital admissions in people with Chronic Obstructive Pulmonary 
Disease. Chapter 2 presents a research journal article which explores the role of 
catastrophising and mindfulness in reported anxiety and hospital admissions in 
people with Chronic Obstructive Pulmonary Disease. Both articles are written for 
publication in the British Journal of Health Psychology (see Appendix A for Author 
Guidelines). Chapter Three is comprised of additional information about the 
methodology of the research study. The thesis portfolio concludes with a complete 
reference list for the whole thesis and an appendix section, which allows the reader to 












Purpose: The aim of the systematic review was to explore the role that anxiety plays 
in hospital admissions for those with Chronic Obstructive Pulmonary Disease 
(COPD). The empirical study aimed to examine whether the frequency of COPD 
related admissions is related to psychological factors (anxiety, depression, 
catastrophising, and mindfulness), disease severity, perceived disability and 
demographic factors. It also sought to examine whether cognitive factors 
(mindfulness and catastrophising) may explain unique variance in predicting anxiety 
and COPD-related admissions when other relevant factors are controlled for. 
Methods: The literature was systematically searched for research related to the 
predictive power of anxiety in relation to COPD related hospital admissions. A postal 
cross-sectional survey of 54 people with COPD examined the psychological profile 
of those who are admitted to hospital for COPD, and if mindfulness and 
catastrophising can predict anxiety and COPD hospital admissions. Correlations and 
multiple regressions were utilised to explore these hypotheses. 
Results: Fourteen studies met inclusion criteria for the systematic review, 
demonstrating mixed results regarding whether anxiety plays a role in COPD related 
hospital admissions. Findings from the empirical study suggest that a significant 
relationship exists between disease severity and number of COPD hospital 
admissions and catastrophising and overall mindfulness predicted 16.3% of variance 
in COPD hospital admissions (non-significant). Anxiety scores were significantly 
correlated with breathlessness, depression, catastrophising and mindfulness with 
catastrophising and mindfulness predicting 22.3% of variance in anxiety 
(significant). 
Conclusions: Further research with robust measures of anxiety and hospital 
utilization are needed to aid our understanding of the role of anxiety in COPD related 
admissions. Further research is necessary to determine if mindfulness and 
catastrophising are useful constructs in predicting anxiety levels and hospital 
admissions in those with COPD. This will help to inform future psychological 
interventions with this population.  
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Purpose: Chronic Obstructive Pulmonary Disease (COPD) is a significant 
worldwide health problem with previous research indicated that anxiety and/or 
depression exacerbate the symptoms. Therefore the aim of this systematic review 
was to explore the role that anxiety plays in hospital admissions for those with 
COPD.  
Methods: The literature was systematically searched for research related to the 
predictive power of anxiety in relation to COPD related hospital admissions. The 
quality of all papers meeting inclusion criteria for the review was assessed.   
Results: Fourteen studies met inclusion criteria for the systematic review, 
demonstrating mixed results regarding whether anxiety plays a role in COPD related 
hospital admissions. Approximately one third of the studies reported evidence that 
anxiety has an impact upon COPD hospital admissions and the majority of these 
were deemed methodologically strongest in this review. However, overall 
comparison of findings in the reviewed studies were mixed, indicating that this may 
be accounted for by the heterogeneity of the key study variables such as sample, 
design, anxiety outcome measures and categorisation of hospitalisation. 
Conclusions: Further research with robust measures of anxiety and hospital 












Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory illness 
without a cure.  It affects 80 million people worldwide (World Health Organisation, 
2010) and is characterised by disabling physical symptoms such as breathlessness, 
chronic cough and sputum production. Living with COPD is related to reduced 
physical functioning (Eisner et al, 2010), reduced quality of life (Punekar, 
Rodriguez-Roisin, Sculpher, Jones, & Spencer, 2007) and increased mortality 
(Connors et al, 1996). COPD accounts for approximately 12.5% of all hospital 
admissions in Britain (NICE, 2004) with COPD being the third most common reason 
for an acute hospital admission in Scotland (NHS QIS, 2010). Most hospital 
admissions occur following an acute exacerbation which is “a sustained worsening of 
the patient’s symptoms from his usual stable state which is beyond normal day-to-
day variations, and is acute in onset” (NICE, 2010, p37). A previous systemat ic 
review and meta-analysis demonstrated that patients with COPD who were 
experiencing anxiety and/or depression were at a greater risk for COPD 
exacerbations compared to those without anxiety and/or depression (Laurin, Moullec, 
Bacon, & Lavoie 2012).  
 
Hospitalisations account for 70% of the treatment costs in COPD (Sullivan, Ramsey, 
& Lee, 2000). Rehospitalisation is common and occurs in up to 30% of patients 
within three months (Price et al 2006), and 60% of patients within 1 year post-
discharge (Garcia-Aymerich et al, 2003; Gudmundsson et al, 2005). The direct 
healthcare costs of COPD to the NHS is estimated at £800 million per annum (Chief 
Medical Officer, 2004).  A minority group of 10% of COPD cases are responsible for 
over 70% of expenditure through high healthcare use (Sullivan et al, 2000). It is clear 
that the economic burden of COPD is large, thereby generating interest in 
understanding the factors which may help us to predict COPD exacerbations, 




Although COPD-related hospitalisations are more frequent in those with more severe 
disease (Wedzicha & Hurst, 2007; Miravitlles et al, 2000), it is also true that there 
are those with more severe COPD who do not attend hospital frequently (Soler et al, 
2004).  Other risk factors for hospital admissions include self-reported health status 
and perceived daily activity levels (Garcia-Aymerick et al, 2006),co-morbidity 
(Miravitlles et al, 2000), depression (Coventry, Gemmell & Todd, 2011), anxiety 
(Benzo et al, 2010), increased age (Gadoury et al, 2005), previous admission 
(Almagro et al, 2006) and use of long-term oxygen therapy (Garcia-Aymerich et al, 
2003). Anxiety is a particularly interesting risk factor to clinicians as it is a common 
experience for those with COPD, with prevalence of clinical anxiety ranging from 
10-55%, generalized anxiety disorder 6-33% and panic disorder 0-41% (Willgoss & 
Yohannes, 2013).  
 
People with COPD are twice as likely to experience anxiety compared to matched 
controls (Eisner et al, 2010). The causal pathway between COPD and anxiety is 
complex in nature and bi-directional. Increased COPD symptoms of breathlessness, 
limited activity and repeated exacerbations are likely to increase anxiety in patients 
with COPD, while research has also demonstrated that increased anxiety can result in 
increased breathlessness (Bailey et al, 2004; Gudmundsson et al, 2005). 
Physiological theories hypothesise that the emotional experience of dyspnoea 
(breathlessness) is processed in the same areas of the brain that processes fear and 
anxiety,  the insula and anterior cingulate cortex (Evans et al, 2002; von Leupoldt et 
al, 2009). Cognitive models such as Clark’s theory of panic (Clark, 1986) suggest 
that panic and anxiety in COPD could result from the catastrophic misinterpretation 
of dyspnea (Sutton, Cooper, Pimm, & Wallace, 1999) as something dangerous, 
resulting in an increase in anxiety. 
 
Anxiety in those with COPD has been suggested as a risk factor for hospital 
admission (Benzo et al, 2010), readmission (Gudmundsson et al, 2005), increased 
exacerbations and longer hospital stays (Xu et al, 2008).  However other studies have 
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failed to find a significant relationship between anxiety and COPD-related 
admissions (Cao , Ong, Eng, Tan, & Ng, 2006; Kim et al, 2000). It is clear that 
research related to the predictive power of anxiety for COPD hospital admissions is 
currently contradictory in nature and the impact of anxiety upon COPD-related 
hospital admission remains unclear. Anxiety is a modifiable risk factor and thus is of 
great interest to researchers and clinicians. 
 
Two systematic reviews (Laurin et al, 2011; Laurin et al, 2012) have previously 
explored the impact of psychological distress (anxiety and depression) on COPD 
exacerbation rates, treated in both the hospital and the community. In these reviews, 
less than half of the selected studies demonstrated an association between levels of 
anxiety and/or depression and an increased risk of worsening symptoms, with the 
majority of these positive associations demonstrated in those treated in the 
community. These reviews were limited to studies published prior to April 2010 
(Laurin et al, 2011) and April 2011 (Laurin et al, 2012) and included studies that had 
general measures of psychological distress alongside individual measures of anxiety 
and depression, and other respiratory conditions besides COPD. Furthermore these 
reviews did not report applying an objective measure of methodological quality to 
enable the reader to understand the relative quality of the studies included. 
 
In this review the focus is on exploring anxiety in isolation, as research has 
demonstrated its prevalence in those with COPD (Eisner et al, 2010) and is solely 
interested in those who access hospital services, as this population are costly to the 
NHS (Sullivan et al, 2000). The review thus aims to explore whether anxiety leads to 
an increase in COPD-related hospital admissions. This study aims to update the 
literature from previous systematic reviews (Laurin et al, 2012, Laurin et al, 2009) 
and specifically explore the impact of anxiety upon hospital admissions in people 
with COPD. Strict inclusion/exclusion criteria will be utilised to ensure the review 






A literature search using the following databases was carried out in July 2013 with 
no early date restrictions: ASSIA, CINAHL, EMBASE, MEDLINE Psychinfo, and 
Web of Science. The search terminology used was: (COPD OR chronic obstructive 
pulmonary disease OR emphysema OR bronchitis OR pulmonary disease) AND 
(mental disorder OR anxiety* OR stress OR distress OR health anxiet* OR panic) 
AND (hospital OR healthcare utilization OR admission* OR readmission* OR 
rehospitalisation* OR emergency OR exacerbation). The search was limited to 
articles available in the English language. 
 
Inclusion criteria 
Articles clearly specifying that the population under study were those with COPD. If 
COPD was one of a number of illnesses under study, the data related to those with 
COPD needed to be accessible. Anxiety as a risk factor for COPD-related 
hospitalisation and its’ relationship to those hospitalisations needed to be measured.  
 
Exclusion criteria  
Articles which did not clearly assess anxiety, its’ relationship to hospitalisation, or 
studies that focused on populations other than those with COPD.  
 
Search results 
The search strategy initially identified a total 1927 publications (205 from ASSIA, 
204 from CINAHL, 920 from EMBASE,158 from MEDLINE, 31 from PsychInfo 
and 409 from Web of Science). This was reduced to 1868 after removing duplicates. 
A search of the Cochrane library of systematic reviews using the search terms 
detailed above revealed that no similar systematic reviews had been published under 
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these terms. The first step of screening the titles of these publications resulted in the 
identification of 148 articles. The second step of manually reviewing the abstracts of 
these papers resulted in 55 articles. In the case of uncertainty over the inclusion of a 
paper, the full article was read.  Reference lists of all studies that met the inclusion 
criteria were read to check for any additional studies which could be relevant for 
inclusion. The full papers were read and 41 did not meet the review’s criteria (see 
Appendix B for detail).  This left 14 papers that were systematically reviewed. Figure 




The quality of all papers meeting inclusion criteria was assessed.  A rating checklist 
was devised by the lead author in consultation with the second author to rate the 
methodological quality of the included studies (see Appendix C). This was based on 
the methodology checklists outlined in the Scottish Intercollegiate Guidelines 
Network (SIGN) 50 Guideline Developer’s Handbook (SIGN, 2008) and the 
STROBE guidelines (van Elm et al, 2008), which were developed for the reporting 
of observational research. Gough and colleagues (2012) recommend that existing 















Records identified through database 
searching (Medline = 158,  
ASSIA =205, CINAHL = 204, 
PsychInfo = 31, Embase = 920,  
Web of Science = 409) 
(Total n =1927) 
     Potential records after  
duplicates removed 
(n = 1868  ) 
Titles screened 
(n =1868 ) 
Records excluded as 
clearly ineligible for 
review 
(n = 1720) 
Abstract screened for 
eligibility 
(n =  148 ) 
Records excluded as not 
eligible for review (see 
Appendix B for detail),  
(n = 93 ) 
Full article read to 
decide if eligible for 
review(n =55 ) 
Studies included in 
synthesis of data 
(n = 14) 
 
Records excluded as not 
eligible for review (see 
Appendix B for detail),  






Characteristics of Included Studies 
Table 1.1 provides an overview of each article, presented alphabetically. All the 
studies included are observational in nature, with five cross-sectional in design 
(Abrams et al, 2011; Alcázar et al, 2012; Cao et al, 2006; Kim et al, 2000; Yohannes 
et al, 2000) , eight cohort in design (Benzo et al, 2010; Coventry et al, 2011; Eisner 
et al, 2010; Fan et al, 2007; Ghanei et al, 2007; Gudmundsson et al, 2005; Laurin et 
al, 2009; Xu et al, 2008) and one case-control study (Soler et al, 2004). The included 
studies were almost equally split between those which were retrospective (n=6 ) and 
prospective in design (n=8), with the study period ranging from  three months to two 
years in retrospective studies and one -two years  in prospective studies. Participants 
were recruited from various settings including outpatients (8 studies; Alcázar et al, 
2012; Benzo et al, 2010; Eisner et al, 2010; Fan et al, 2007; Kim et al, 2000; Laurin 
et al, 2009; Xu et al, 2008; Yohannes et al, 2000),  hospitalised patients (5 studies; 
Cao et al, 2006;  Coventry et al, 2011; Ghanei,  Aslani, AzizAbadi-Farahani, Assari, 
&, Saadat, 2007; Gudmundsson et al, 2005; Soler, Sánchez, Román,  Martínez, &  
Perpiñá, 2004)  and one from medical records (Abrams et al, 2011). Overall, the 
sample sizes ranged from n=43 to n=26, 591 and the percentage of women in the 
studies ranged from 0 - 75%.  
 
Quality of Included Studies 
Table 1.2 provides an overview of the quality ratings for each study in relation to the 
systematic review question of whether anxiety impacts upon COPD hospital 
admissions. According to the quality criteria, Eisner et al (2010), Gudmundsson et al 
(2005) and Xu et al (2008) were the strongest methodologically, closely followed by 
Fan et al (2007) and Laurin et al (2009) while Soler et al (2004) was the weakest 
methodologically with all other studies falling on a continuum between the two.
18 
 



























































30 day readmission 









2 years prior to 
hospital 
admission 
Anxiety:  6.7% of sample 
Anxiety was associated with  
an increased risk for 
readmission  

























duration and visits to 
ER 
Categories:  
   0 admission 




HADS – A Anxiety: 32.7% in 
hospitalised Vs 18.9%  in 
non- hospitalised  
(p <0.05). 
No significant association 
between  anxiety and 
hospitalisations  

































Hospitalisation in 12 
months. Categories:  
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≥ 1 admission 
Source 
Self-report- 
questionnaires at 1 
& 2 mths initially 
and then every 2 
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Anxiety associated with 
hospitalisation (P<.001). 
Anxiety was a significant 
predictor of hospitalisation  
(OR 1.75;  CI 1.13 – 2.70). 
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within year  
Categories:  
   0 admission 
≥ 1 admission 
Source 
Hospital Records 
HADS- A Anxiety in sample: 58% 
Anxiety did not predict 
 readmission to hospital. 
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Anxiety associated greater 
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those without anxiety (HR 
1.39; 95% CI 1.007-1.90) 
Impact of anxiety mediated 
by COPD severity  
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significant predictor of 
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All scores for anxiety within 
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STAI-S 16 (10) 
STAI-T 22 (11) 
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present;  
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between anxiety and 
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Among patients with at least 
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GMS (≥3 = 
case/clinical 
anxiety) 
Clinically Anxious: 18% 
Anxiety was a predicting  
factor for frequency of 
hospital admission for 
COPD (p≤0.05). It 
explained 4% of variance in 
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HADS-A = Hospital Anxiety and Depression Scale – Anxiety scale; STAI = Strait-Trait Anxiety Inventory; GMS=Geriatric Mental 










Table 1.2. Quality ratings of included studies 
Methodological Quality Criteria 
 
 











































































































































































































































































































































































































































Representativeness   
The included studies were explored to investigate whether the sample was 
representative of a COPD population and thus findings could be generalised. Most 
reviewed studies (n=13) used convenience sampling and invited all consecutive 
patients who met the inclusion/exclusion criteria to participate in the research. 
Systematic sampling was used by Ghanei et al (2007) while no information about 
sampling method was provided by Soler et al (2004). Most studies (n=14) described 
a diagnosis of COPD as an inclusion criteria, while Benzo et al (2010) and Fan et al 
(2007) specified severe emphysema as the necessary diagnostic criteria, which is 
only one diagnosis which falls under the COPD umbrella. Two studies focused 
exclusively upon Veterans resulting in limited female participants (0-3%; Abrams et 
al, 2011; Kim et al, 2000). Some of the studies in this review focused on people with 
COPD who were receiving ongoing extra nursing support in the community 
(Coventry et al, 2011) or had completed self-management training through 
completion of a pulmonary rehabilitation Programme (Benzo et al, 2010, Fan et al, 
2007). Abrams et al (2011)’s excluded those who did not receive any ongoing 
outpatient care. It may be that some people with COPD do not engage with 
outpatient care but rather only utilise inpatient care. Two studies further excluded 
those with previous psychiatric diagnoses (Cao et al, 2006; Yohannes et al, 2000) 
while  Kim et al (2000) study excluded those younger than 60 years of age. It is 
likely that specific inclusion and exclusion criteria and focusing on specific cohorts 
of those with COPD is likely to impact upon the findings and the generalisablilty of 
their findings. 
 
In most reviewed studies (n=13), the samples were self-selected and could refuse to 
participate or drop out of the study at any time. The remaining study (Abrams et al, 
2011) was based on medical records and did not involve any patient contact.  Eight 
of the reviewed studies reported some detail in relation to attrition and five studies 
did not give sufficient detail (Alcázar et al, 2012; Ghanei et al, 2007; Soler et al, 




In relation to specific sample characteristics, only one study (Gudmundsson et al, 
2005) reported a sample with gender, age and severity of COPD which is 
representative of those with COPD in the general population. This is not unusual 
given that convenience sampling was utilised in most included studies.  Overall there 
were fewer women than men in the included studies. Seven studies reported less than 
35% women in their sample (Abrams et al, 2011; Alcázar et al, 2012; Cao et al, 
2006; Ghanei et al, 2007; Kim et al, 2000; Soler et al, 2004; Xu et al, 2008), and all 
other studies, excluding Benzo et al (2010) had a more proportionate divide between 
the sexes. Severity of COPD varied greatly between samples. The sample in Ghanei 
and colleagues’ (2007) study had ‘less severe’ disease and only ‘severe’ and ‘very 
severe’ illness reported in three samples (Benzo et al, 2010; Fan et al, 2007; Soler et 
al, 2004). Meanwhile, Cao et al (2006)’s study was comprised of participants whose 
disease severity varied across a continuum (i.e. mild to very severe). COPD is 
common in older people with the majority of the included studies demonstrating a 
good age-range, including those over 65 years. However, research by Eisner et al 
(2010) limited their sample to those aged between 40 – 65 years.  
 
Power and Statistical Analysis 
All reviewed studies reported descriptive statistics, and utilised appropriate 
univariate and multivariate analyses to examine the role of anxiety in hospitalisation, 
in accordance with whether the data collected was continuous or categorical. The 
majority of studies (n=13) described demographic and clinical confounding factors 
which could have an impact upon hospitalisation and any necessary adjustments in 
statistical analysis. Due to the large amount of variation in possible covariates, it is 
impossible to directly compare the studies in relation to their covariates.  The author 
utilised the G*power computer programme to calculate details about power analysis. 
Six studies had a sufficient sample to enable power of at least .8 (Abrams et al, 2011; 
Eisner et al, 2010; Fan et al, 2007; Gudmundsson et al, 2005; Xu et al, 2008; 
Yohannes et al, 2000), two studies to enable power of at least .7 (Benzo et al, 2010; 
Laurin et al, 2009) and six studies to enable power of less than .7 (Alcázar et al, 
2012; Cao et al, 2006; Coventry et al, 2011; Ghanei et al, 2007; Kim et al, 2000; 
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Soler et al, 2004). Those with lower power generally had a smaller sample size and a 
larger number of predictor variables or confounding variables (e.g. Cao et al,  2006 
had 19 predictor variables)  managed in multivariate analysis. Underpowered studies 
are at an increased risk of a Type II error. 
 
Outcome Measures 
Increased use of hospitalisation was measured in a number of different ways in the 
included studies: thirty day hospital readmissions (Abrams et al, 2011), number of 
hospitalisations in designated time (Alcázar et al, 2012; Benzo et al, 2010; Cao et al, 
2006; Coventry et al, 2011; Eisner et al, 2010; Fan et al, 2007; Ghanei et al, 2007; 
Gudmundsson et al, 2005; Kim et al, 2000; Laurin et al, 2009; Soler et al, 2004; Xu 
et al, 2008; Yohannes et al, 2000), emergency department visit in designated time 
(Alcázar et al; 2012, Eisner et al, 2010; Fan et al, 2007; Kim et al, 2000; Laurin et al, 
2009; Soler et al, 2004), length of hospital stay (Alcázar et al, 2012; Xu et al, 2008). 
Hospitalisation was recorded from medical records alone in the majority of studies 
(n=9), through patient self-report questionnaires at set time-points throughout  the 
follow-up period (Benzo et al, 2010), or both self-report methods alongside the use  
of hospital records (Gudmundsson et al, 2005; Laurin et al, 2009; Xu et al, 2008; 
Yohannes et al, 2000). Furthermore, studies varied in whether they viewed 
hospitalisation as a continuous variable (n=4) or if they chose cut off points to 
categorise hospital use. The reviewed studies further varied in how they classified 
hospitalisations with the majority (n= 7) distinguishing between no hospital 
admissions and at least one hospital admission whereas other studies classified 
people according to frequent hospital admissions (e.g. ≥2 admissions) and less 
frequent admissions (n=3).   
 
Similarly, anxiety was measured in a number of different ways in the studies selected 
in this review. The majority of studies utilised self-report measures which act as 
screening tools for anxiety (n=10) and had good validity and reliability. Measures 
included Hospital Anxiety and Depression Scale-Anxiety subscale (HADS; n=7; 
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Zigmond, & Snaith, 1983), Strait-Trait Anxiety Inventory (STAI; n=2; Spielberger,  
Gorsuch,  Lushene, Vagg,  & Jacobs, 1983) and Beck Anxiety Inventory (BAI; n=1; 
Beck,  Epstein,  Brown,  & Steer, 1988) while one study used a single item from the 
Quality of Well-Being Scale (Kaplan, Bush, & Berry, 1975). This study was the only 
study in the review to use a single item as a ‘stand alone’ anxiety measure. Although 
the overall measure’s psychometric properties are well established (Kaplan, 
Anderson, & Ganiats, 1993), there is no known evidence validating the use of the 
single item. A further study used psychiatric diagnostic labels of anxiety from the 
medical notes (Abrams et al, 2011), but no information was given in relation to who 
assigned the diagnosis and thus we cannot be confident of it’s’ reliability. The 
remaining studies utilised standardised diagnostic interview schedules including the 
Anxiety Disorders Interview Schedule anxiety (ADIS-IV ;  Brown,  DiNardo, & 
Barlow, 1994) and the Geriatric Mental State Schedule (GMS;  Copeland et al, 
1976), which have demonstrated good validity and reliability in diagnosing 
psychiatric disorders. 
 
Key findings in the context of methodological quality of studies 
Approximately a third of the included studies (5/14) reported evidence that anxiety 
has an impact upon COPD hospital admissions (See Table 1.1). This included three 
of the methodologically strongest studies from this review. Yohannes et al (2000) in 
a retrospective study demonstrated that those who were clinically anxious had an 
increased number of hospital admissions in the past year. Gudmundsson et al (2005) 
in a prospective study demonstrated an association between anxiety and 
rehospitalisation in those with lower health status, while Eisner et al (2010) 
suggested that the negative impact of increased anxiety upon COPD hospital 
admissions was mediated by the severity of COPD in their study. Similar findings 
were reported by two further studies. Benzo et al (2010) demonstrated in their 
prospective study that anxiety was a significant predictor of hospitalisation and 
Abrams et al (2011) reported that anxiety was associated with an increased risk of 
readmission within thirty days (Abrams et al, 2011).  
30 
 
The studies that found evidence for the relationship between increased anxiety and 
hospitalization were heterogeneous and had many differences in study design, 
sample and outcome measures (See Table 1.1 for detail). However it is worth noting 
that the majority of those studies (n=4) which found evidence for a relationship 
between increased anxiety and hospitalisation were well powered at least .8 while 
one was powered at least .7 (Benzo et al, 2010).  
 
The remaining two of the methodologically strongest studies from this review failed 
to find an association between anxiety and hospitalisation, despite both studies being 
well-powered (at least .8).   Xu et al (2008) reported no significant relationship 
between anxiety and hospitalisation in their study. However they further reported 
that anxiety was associated with an increased length of hospital admission. It is 
worth noting that within this sample, there appeared to be lower levels of baseline 
anxiety (9.6%) when compared to some of the other studies within the review (e.g. 
15% Eisner et al, 2010; 41% Gudmundsson et al, 2005) . Furthermore Xu et al 
(2008) suggest that the loss of 8% of their sample at follow-up may have acted as a 
potential bias, as those who dropped out may have had higher levels of psychological 
distress. Fan et al (2007) failed to find any association between anxiety and 
hospitalisation. The sample which took part in this research had previously 
completed a pulmonary rehabilitation group, which is likely to have improved their 
self-management capabilities and may have impacted upon their hospital use. The 
relatively weakest methodological study further failed to find any evidence for 
anxiety impacting upon hospital use (Soler et al, 2004). This study along with the 
majority of all the remaining studies (n= 6) which failed to find an association were 
insufficiently powered, which is likely to increase the risk of a Type II error. Larger 
sample sizes may have allowed a greater exploration of the relationship between 







This systematic review aimed to summarise research findings exploring whether 
anxiety had an impact upon hospitalisations in COPD. Overall the review yielded 
mixed findings, with evidence that increased anxiety resulted in increased 
hospitalisation admissions in approximately a third of studies. The heterogeneous 
nature of the key variable in the included studies is an important factor in helping to 
understand the varying findings.  
 
The representativeness of the samples (e.g. gender, sex, severity) studied within this 
review was variable, which impacts upon the generalizability of the findings of this 
review. Many of the studies had an unequal proportion of males to females. Although 
COPD has historically been more prevalent in men, recently prevalence seems to be 
becoming equal (Mannino & Buist, 2007) while hospitalisation rates have been 
approximately equal for men and women since 1995 (Mannino, Homa, Akinbami,  
Ford, & Redd, 2002). Furthermore, women are significantly more likely to have a 
clinical anxiety disorder (Willgoss & Yohannes, 2013). The fact that fewer women 
were included in some of the studies reviewed may have resulted in an 
underestimation of the role of anxiety in hospital admissions Two studies within the 
review excluded those with a psychiatric history, which is likely to have impacted 
upon the strengths of the associations seen (Cao et al, 2006; Yohannes et al, 2000). A 
further factor to consider is the level of support and self-management training which 
participants’ had access to and how this may impact upon hospital admissions and/or 
anxiety levels . Coventry & Hind (2007) demonstrated that pulmonary rehabilitation 
programmes can reduce anxiety symptoms in those with COPD.  A recent systematic 
review (Zwerink et al, 2014) reported that self-management interventions within 
COPD resulted in a reduction of respiratory related hospital admissions. It is likely 
that these and other characteristics of the samples will have impacted upon the 





The two main variables measured in the current review were hospitalisation and 
anxiety and it is clear from this review that there is wide variability in how this is 
measured currently in COPD research. Hospitalisation which was measured solely by 
self-report is likely to be susceptible to recall bias. The variability in how 
hospitalisation was categorised, such that some study’s label ‘1’ admission as 
‘frequent’ while others label ‘2 or more’ admissions as frequent, creates a difficulty 
when trying to compare and synthesise findings across studies. Although reliable and 
valid anxiety measures were used by the majority of the studies, only two studies 
utilised a structured psychiatric interview (Laurin et al, 2009; Yohannes et al, 2000). 
The majority of the other studies used self-report questionnaires which act as a 
screening measure for anxiety but do not provide a clinical diagnosis (Vogele & von 
Leupoldt, 2008). Self-report measures of anxiety are subjective and susceptible to 
bias.   Furthermore the self-report measures used within the included studies have 
some weaknesses when used with the COPD population. The BAI has somatic 
anxiety symptoms which may overlap with symptoms of COPD (Kabacoff, 1997). 
Similarly, Martin (2005) suggests that the autonomic arousal component of the 
HADS may overlap with the somatic symptoms of COPD (Martin, 2005). A clinical 
interview such as the ADIS-IV may be a more robust method of assessing and 
diagnosing anxiety in clinical research with this population. The ADIS-IV is a more 
objective measure of anxiety as it is a semi-structured diagnostic measure created 
according to the DSM-IV criteria. It has demonstrated good clinician inter-rater 
reliability (Brown, Di Nardo, Lehman, & Campbell, 2001). This measure may too 
time-consuming for day-to-day clinical work, but is ideal for clinical research due to 
its structure and it’s reliability, allowing for a more valid comparison across 
participants and across studies. 
 
These various weaknesses are likely to imply that the current studies, and this review 
may have underestimated the overall association between anxiety and 




Limitations of the review 
 The primary limitation of the current review is the heterogeneity between studies in 
relation to study sample, study design, anxiety outcome measures and categorisation 
of hospitalisation, which makes comparison across studies difficult. Due to this 
variability across included studies, it was decided not to pool data or conduct a meta-
analysis, as the results would be misleading. The review was limited by time 
constraints and therefore study authors were not contacted for additional information 
and inter-rater reliability checks related to the ratings of the methodological quality 
for the studies were not utilised. This may have resulted in subjective bias in study 
ratings. Furthermore publication bias may have been introduced as this review 
excluded unpublished and non-English language papers. This is of particular concern 
in a systematic review of observational studies as there is a greater threat of 
publication bias than with randomised controlled trials (Easterbrook et al, 1991). 
 
Study implications and future research 
The results for this systematic review suggest that anxiety may be an important  
modifiable factor, which is associated with a higher risk of hospitalisation in those 
with COPD. Providing screening and targeted interventions for anxiety in this 
population could potentially prevent unnecessary hospital admissions and lead to 
monetary savings in the NHS. NICE (2010) recommend that those with COPD are 
screened for distress. Coventry & Hind (2007) reported a reduction in anxiety for 
those people with COPD who attended pulmonary rehabilitation. Baraniak & 
Sheffield (2011) in a systematic review and meta-analysis demonstrated that 
psychological interventions can have a positive impact upon anxiety in those with 
COPD. Research evaluating the direct impact of these interventions on COPD 
hospitalisations and on the economic implications are needed.  
 
Due to the heterogeneous  designs of the studies involved in this review, we were 
unable to establish a cause-effect relationship. Future well-powered prospective 
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studies with robust measures of hospitalisation and anxiety are needed to truly 
answer the review question.  
Conclusion 
The current review provides some strong evidence that anxiety may play an 
important role in hospitalisations in those with COPD, with approximately a third of 
the included studies demonstrating a positive relationship between anxiety and 
COPD hospitalisations. Those studies of higher quality within this review supported 
this association.  Future studies with more robust measures of anxiety and hospital 
utilization would further aid our understanding of the role of anxiety in COPD 
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Purpose: Research to date has indicated that COPD is possibly affected by anxiety, 
whereby anxiety serves as a possible risk factor for hospital readmission, 
exacerbations of symptoms and longer hospital stays. The present study therefore 
aimed to examine whether the frequency of COPD related admissions is related to 
psychological factors (anxiety, depression, catastrophising, and mindfulness), disease 
severity, perceived disability and demographic factors. It also sought to examine 
whether cognitive factors (mindfulness and catastrophising) may explain unique 
variance in predicting anxiety and COPD-related admissions when other relevant 
factors are controlled for. 
Methods: A postal cross-sectional survey of 54 people with COPD examined the 
psychological profile of those who are admitted to hospital for COPD, and if 
mindfulness and catastrophising can predict anxiety and COPD hospital admissions. 
Correlations and multiple regressions were utilised to further explore these 
hypotheses. 
Results: Findings from the empirical study suggest that a significant relationship 
exists between disease severity and number of COPD hospital admissions and 
catastrophising and overall mindfulness predicted 16.3% of variance in COPD 
hospital admissions (non-significant). Anxiety scores were significantly correlated 
with breathlessness, depression, catastrophising and mindfulness with catastrophising 
and mindfulness predicting 22.3% of variance in anxiety (significant). It is clear that 
mindfulness and catastrophising may be important constructs in predicting anxiety 
and hospitalisations in those with COPD. 
Conclusions: Further research is necessary to determine if mindfulness and 
catastrophising are useful constructs in predicting anxiety levels and hospital 
admissions in those with COPD. This will help to inform future psychological 









COPD is an umbrella term used to describe airflow obstruction due to chronic 
bronchitis, emphysema, or both. It is a serious long-term and progressive illness with 
no cure. COPD is currently the UK’s fifth biggest killer disease (British Lung 
Foundation, 2007) but is expected to be the third by 2020 (Murray & Lopez, 1997). 
The total number of people with COPD in Scotland was estimated at nearly 100,000 
in 2007 and is projected to increase by 33 per cent between 2007 and 2027(Audit 
Scotland, 2007). COPD is classified according to a severity banding ranging from 
mild to very severe and key symptoms include cough, sputum production, fatigue 
and shortness of breath (dyspnoea). The benefits of medical interventions are limited 
and therefore what a person does to help manage their own condition (e.g. self-
management strategies) is very important (Booker, 2005).  
 
 
COPD is the third most common reason for an acute hospital admission in Scotland 
(NHS QIS, 2010). In 2009, 1552 COPD-related emergency hospital admissions were 
recorded in Lothian (Lothian Respiratory MCN, 2011). Most hospital admissions 
occur following an acute exacerbation which is ‘a sustained worsening of the 
patient’s symptoms from his usual stable state which is beyond normal day-to-day 
variations, and is acute in onset’ (NICE, 2010, p37). Hospitalisations account for 
70% of treatment costs (Sullivan et al, 2000), with the direct cost to the NHS in 
Scotland estimated at more than £98.5 million in 2004/05 (Audit Scotland, 2007).  
Understanding those factors which help predict hospital admission would allow 
intensive interventions to be targeted at the most appropriate people. 
 
 
 Although COPD-related hospitalisations are more frequent in those with severe 
disease (Wedzicha et al, 2007), self-reported health status and perceived daily 
activity levels are good predictors of hospitalisations regardless of disease severity 
(Benzo et al, 2010; Garcia-Aymerick et al, 2006). Other risk factor for hospital 
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admissions include increased age, being female (Alcázar et al, 2012; Xu et al, 2008, 
Coventry et al, 2011), smoking (Godtfredsen, Vestbo, Osler & Prescott, 2002), use of 
oxygen therapy (Xu et al, 2008), co-morbidities (Alcázar et al, 2012; Xu et al, 2008 
and lower socio-economic status (Coventry et al, 2011). Living with a partner can act 
as a protective factor in relation to readmission (Crockett, Cranston, Moss, & Alpers, 
2002; Alcazar et al, 2012).  
 
Anxiety has been suggested as a possible risk factor for hospital readmission 
(Gudmundsson et al, 2005), increased exacerbations and longer hospital stays (Xu et 
al, 2008). However other studies have failed to find a significant relationship 
between anxiety and COPD-related admissions (Cao et al, 2006; Coventry et al, 
2011; Kim et al, 2000; Ng et al, 2007). Research further suggests that depression in 
those with COPD is significantly associated with an increased risk of exacerbations 
(Fan et al, 2007) hospitalisations (Xu et al, 2008) and readmission (Coventry et al, 
2011). However, other studies have failed to find a significant association between 
depression and COPD-related hospital readmission (Cao et al, 2006; Gudmundsson 
et al, 2005). It is worth noting that many of these studies have methodological 
weaknesses including small or limited sample sizes (Kim et al, 2000, Cao et al, 2006) 
or have included other patient groups alongside COPD patients (Dahlen & Jahsen, 
2002). The impact of psychological distress upon COPD-related hospital admission 




People with COPD are two to three times more likely to experience mental health 
issues compared with the general population (Andaenaes & Kalfoss, 2004 ; Naylor et 
al, 2012) with anxiety and depression estimated at 8-80% and 6-74% respectively in 
COPD (Yolhannes et al, 2010). Demographic and clinical characteristics have shown 
an association with increased anxiety including age, gender, (Di Marco, Verga & 
Reggente, 2006; Eisner et al, 2010), smoking (Patton et al, 1996), depression (Kunik 
et al, 2005), COPD severity (Eisner et al, 2010) and increased breathlessness ((Di 
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Marco et al, 2006). Having comorbid anxiety and/or depression alongside COPD can 
impact negatively upon COPD prognosis and interfere with illness self-management 
through poor adherence to recommended treatment (Fan et al, 2008). A recent meta-
analysis demonstrated that the presence of co-morbid depression or anxiety increased 
the risk of mortality in those with COPD (Atlantis, Fahey, Cochrane, & Smith , 
2013).   
 
Clark's cognitive model of panic aids our understanding of why people with COPD 
may experience panic and anxiety (Clark, 1986). COPD's key symptom of 
breathlessness can be understood as a dangerous threat and as imminently 
catastrophic (e.g. death, suffocation), resulting in increased arousal and a 
panic/anxiety reaction. It is easy to understand how those living with COPD may be 
particularly susceptible to panic and anxiety attacks as breathlessness is a central 
symptom of both COPD and panic (Heslop et al, 2009) and is experienced as the 
most disabling symptom by patients (Hill, Geist, Goldstein & Lacasse, 2008). 
Psychophysiological research hypothesises that the emotional experience of 
dyspnoea (breathlessness) is processed in the same areas of the brain that processes 
fear and anxiety (Evans et al, 2002; von Leupoldt et al, 2009). Research has further 
demonstrated that for people with COPD the hyperventilation which accompanies 
anxiety worsens shortness of breath by causing bronchoconstriction (narrowing of 
the airways in the lungs) and lung hyperinflation (expansion of the lungs) (Smoller & 
Otto, 1998).  
 
 
There are a number of psychological factors that may impact upon a person’s 
psychological distress when living with COPD. The current research will focus upon 






Increased rates of catastrophic thoughts about COPD (e.g. beliefs about suffocating) 
have been shown to be related to increased anxiety (Livermore et al, 2008) and panic 
(Livermore et al, 2012), which is in line with Clark’s model of panic. Catatrophising 
about COPD may result in an increased focus on COPD symptoms and 
misinterpreting them (Guerney-Smith et al, 2002, Sutton et al, 1999). The severity of 
catastrophic thoughts is a better predictor of anxiety than demographic or disease 
factors (Sutton et al, 1999), with an individual’s ability to cope with COPD being 
more influenced by their interpretation of their symptoms rather than objective 
characteristics of their illness (e.g. severity banding) (Kaptein et al, 2008).  
Breathlessness can precipitate anxiety and vice versa with psychological outcomes 
linked to both the physical manifestation of the disease and a person’s interpretation 
of that (Baraniak et al, 2011). Increased catastrophic misinterpretation of COPD 
and/or anxiety symptoms is likely to result in an increase in hospitalisation and the 
author is unaware of any previous research in this area. 
 
 
Mindfulness has been theorised to be an important construct in psychological 
functioning generally and anxiety problems specifically (Zvolensky et al, 2006). One 
of the most widely cited definitions for mindfulness is that of Bishop et al (2004) 
who argue for two key components which are: the self-regulation of attention 
(awareness) to the current experience and a non-judgmental acceptance of the present 
moment. These two components have been supported by empirical research (Coffey, 
Hartman, & Fredrickson, 2010). Mindfulness can be conceptualized as a 
dispositional/trait variable and describes an individual's level of mindfulness in day 
to day life (Brown & Ryan, 2003). Low trait mindfulness is associated with 
depression (Brown & Ryan, 2003) and social anxiety (Brown & Ryan, 2003). High 
trait mindfulness is associated with greater life satisfaction, positive mood and sense 
of autonomy (Brown & Ryan, 2003). Baer and colleagues,  (2008) suggest that the 
mindfulness facets of ‘describing’, ‘awareness’, ‘non-reactivity’ and ‘non-judging’ 





In relation to anxiety it is conceptualised that a person with higher trait mindfulness 
will develop a non-judgmental awareness of each moment, be able to observe a 
situation without getting caught up in it, and thus not catastrophise when 
experiencing unpleasant bodily sensations, (e.g. breathlessness, Erisman & Roemer, 
2012; Hayes et al, 1996; Mental Health Foundation, 2010). Greater trait mindfulness 
is associated with lower distress and disability in people with chronic pain 
(McCracken et al, 2007) while low trait mindfulness is related to greater 
catastrophising in people with chronic pain (Schutze et al, 2010). Higher trait 
mindfulness has been associated with lower healthcare utilization (Brown & Ryan, 
2003).  In recent research (Consedine & Butler, 2013) with a healthy adult sample, 
greater ‘observe’ scores (noticing and attending to internal stimuli) were associated 
with increased healthcare use while those with greater ‘non-react’ scores (allow 
thoughts and feelings to come and go) described less healthcare use. However the 
sample in their study were young healthy adults which may not be representative of a 
more unwell sample. Furthermore, healthcare utilisation was collected by self-report 
questionnaire which may have led to a bias in information presented, particularly as 
they were asked to recall information for the past year. There has been limited 
mindfulness research in a COPD population with only one known study to date, 
which did not measure mindful skill achievement or anxiety and had a high drop out 
rate (40%) (Mularski et al, 2009). No research to date has studied mindfulness in 
relation to COPD-related hospital admissions.  
 
 
The current study hopes to build upon previous psychological research in COPD and 
aims to add to the current literature in relation to the psychological profile of those 
who are admitted to hospital for COPD related issues. The two main aims are to (1) 
explore whether the frequency of COPD related admissions in a 12 month period is 
related to psychological factors (anxiety, depression, catastrophising, and 
mindfulness), disease severity, perceived disability and demographic factors, and (2) 
examine whether cognitive factors (mindfulness and catastrophising) may explain 
unique variance in predicting anxiety and COPD-related admissions when other 





The number of COPD-related admissions to hospital over the past year will be 
negatively correlated with mindfulness, and positively correlated with psychological 





Anxiety will be positively correlated with catastrophising, depression, disease 





Catastrophising and mindfulness will be significant predictors of anxiety and 
frequency of COPD admissions to hospital, when variance shared with confounding 
























Potential participants included any person with Chronic Obstructive Pulmonary 
Disease (COPD) who were listed on the records of a Lothian based hospital (Western 
General Hospital, Royal Infirmary Hospital, St John’s Hospital). They had to meet 
the following inclusion and exclusion criteria. 
Inclusion: 
 A diagnosis of COPD (GOLD criteria according to spirometry) as recorded 
on Trak records. 
 Adult (18 years +). 
 Male or Female. 
 Fluent in written English as the questionnaires used in the current study are 
normed in the English language. 
Exclusion: 
 A diagnosis of a dementia recorded in the medical notes. This may have 
impacted upon the participants’ understanding of the questions being asked in 
the questionnaire pack. 
 Patients currently receiving palliative/end of life treatment. Completing the 
questionnaire pack could be viewed as an unfair burden for them. There are 
no set criteria on how COPD sufferers needing palliative care should be 
identified (White et al, 2011). However prognosis is known to be related to 
severe airflow obstruction (< 30% FEV1), frequent exacerbations, a 
requirement for long-term oxygen therapy, development of cor pulmonale  
and clinician’s expectation of death within the next 12 months (Seamark et al, 
2007). Judgment of when treatment becomes palliative is usually a matter of 
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experienced clinical judgment (Seamark et al, 2007) and thus the researcher 
sought the expertise and advice of Lothian specialist respiratory nurses to 





A list of potential participants was created from routine data collected centrally by 
NHS Lothian. This list was created by a data manager within Performance Review. 
The list initially contained a list of people who have had at least one COPD-related 
hospital admission in Lothian in the past three years. This time period (three years) 
was utilised to ensure people who had  not been admitted in the  past year (12 
months) were also identified.  A filter was then applied by the data manager to 
identify those people who had 0, 1, 2 or 3+ admissions in the past 12 months.    
 
The information gathered included the contact details of each participant and  
number of COPD-related hospital admissions. No personal information about 
potential participants was given to the Chief Investigator. A member of staff from the 
Lothian Respiratory Team, who was already a part of the potential participants 
clinical care team, received the list of potential participants. Therefore no 
information was provided to the Chief Investigator prior to consent being obtained 
from the participants themselves. At this stage the list of names was examined by a 
Specialist Respiratory Nurse to ensure they met the criteria for inclusion in the 
current study (as detailed above). Only those potential participants who met the study 
criteria (as detailed above) were invited to take part in the research study.  
 
The current study utilised stratified sampling to randomly sample across the four 
frequency groupings (3 or more, 2, 1 or 0 COPD-related hospital admissions in the 
52 
 
past year) to ensure the sample was as representative as possible. A randomising 
computer programme (www.randomizer.org) was utilised for this purpose. 
 
Procedure: 
NHS ethical approval for the research study was obtained from the South East 
Scotland Research Ethics Committee. Once potential participants were identified, an 
invitation letter, information sheet, consent form, questionnaire pack and stamped 
addressed envelope were sent to them by a member of the Respiratory team. 
 
At this point permission was sought from the participants for the chief investigator to 
access their online trak records so that medical information such as severity of illness 
and co-morbid conditions could be accessed. Potential participants were encouraged 
to contact the researcher if they have any questions related to the study or if they 
required any additional support to complete the questionnaire pack (e.g. prefer to 
complete it over the telephone rather than complete a hard copy). If a participant took 
part in the research study a letter was sent to their GP to inform them of their 
participation. If the potential participant did not return the questionnaire pack within 
4 weeks, a reminder letter with a copy of the invitation letter, questionnaire pack, 
information sheet, consent form and a stamped addressed envelope was sent, in case 
the initial copy had been misplaced. If they did not return the second questionnaire 




 Demographic information  
Information such as gender, age, marital status, and occupational status, current 
living situation, co-existing medical conditions, and smoking status was gathered. 
Where possible this information was gathered from Trak records (with the 
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participants’ permission) and the rest of the information was gathered through self-
report from participants. 
 
 Clinical Information (COPD severity banding) 
This information was gathered from Trak records (with participants’ permission). 
Lung function was measured by forced expiratory volume in 1 second (FEV1) by 
spirometry tests (breathing tests) carried out by trained professionals. Classification 
of severity and COPD stages (mild- very severe) according to the Global Initiative 
for Chronic Obstructive Lung Disease (GOLD) guidelines was recorded ( See 
Appendix D) .  
 
 COPD Healthcare Utilisation 
The number of COPD related hospital admissions (0+ admissions) to Lothian based 
hospitals (Western General Hospital, Royal infirmary, St John’s Hospital) over the 
past 12 month period was ascertained centrally by Performance Review from data 
collected centrally by NHS Lothian. 
 
 MRC (Medical Research Council) Dyspnoea Scale (Fletcher, 1960) 
(disability associated with COPD) 
This scale is a measurement of the effect of breathlessness on daily activities. The 
MRC breathlessness scale does not quantify breathlessness itself. Rather, it 
quantifies the disability associated with breathlessness. The MRC dyspnoea scale 
asks a person to indicate the extent to which their breathlessness affects their 
mobility. The scale has five statements that describe almost the entire range of 
respiratory disability from none (e.g. ‘I only get breathless with strenuous exertion’ 
Grade 1) to almost complete incapacity (e.g. ‘I am too breathless to leave the house’ 
Grade 5). The score correlates well with the results of other breathlessness scales, 
lung function measurements (Mahler & Wells, 1988) and with direct measures of 
disability such as walking distance (American Thoracic Society, 1999). It was 
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utilised in the current study as it compliments the FEV1 measurement (severity 
banding of the disease) in more fully describing disability in those with COPD 
(Bestall et al, 1999). 
 
 Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) to 
measure anxiety and depression  
The HADS consists of 14 items divided into 7 items in the anxiety subscale and 7 
items in the depression subscale, without the confounding of somatic symptoms 
related to physical illness. The participant is asked to choose from 4 responses for 
each question (scored 0-3). Each subscale score can range from 0-21 and contains 
cut-off points to indicate whether someone is ‘within the normal range’, or in a 
‘mildly’, ‘moderately’ or ‘severely’ disordered state or whether a person’s score 
indicates ‘normal’ range (0-7), ‘possible clinical disorder’ (8-10) or ‘probable 
clinical disorder’ (11-21). It was developed for use in general medical outpatient 
clinics, and is used widely in clinical practice and in research (Herrmann, 1997). The 
HADS was found to perform well in assessing the symptom severity and caseness of 
both anxiety disorders and depression in somatic, psychiatric and primary care 
patients and in the general population (Bjelland, Dahl, Haug & Neckelmann, 2002). 
Internal consistency measured by cronbach’s alpha was 0.93 for anxiety and .90 for 
depression (Moorey et al, 1991). It has further been reported to have good face 
validity (Zigmond & Snaith, 1983). The HADS has been used in previous research 
with people with COPD (Howard et al, 2010; Xu et al, 2008). Cronbach’s alpha in 
the current study was.86 for anxiety subscale and.81 for the depression subscale. 
. 
 Interpretation of Breathing Problems Questionnaire short version (IBPQ –S) 
(Gurney-Smith et al, 2002) to measure catastrophic beliefs related to COPD 
The IBPQ-S is a self-report questionnaire which was developed  by adapting the 
Interpretation of Breathing Problems Questionnaire (Sutton et al., 1999), as a 
measure to assess catastrophic thinking related to the physiological symptoms of 
COPD (i.e. illness specific catastrophic thinking). It consists of eight scenarios 
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describing the experience of a symptom commonly associated with COPD, either in 
a safe or unsafe situation (e.g. being breathless on a bus). Each scenario is followed 
by three open-ended questions designed to elicit catastrophic cognitions. Research 
has indicated that IBPQ-S catastrophic cognitions were related to anxiety triggered 
by COPD symptoms. It has demonstrated good inter-rater reliability and internal 
consistency (.87) and good overall construct validity (Gurney-Smith et al, 2002). It 
has been used in previous research with COPD patients evaluating the efficacy of a 
pulmonary rehabilitation group  (Livermore et al, 2010) and in a study which has 
investigated the factors that predict panic psychopathology in COPD (Livermore et 
al, 2012). Cronbach’s alpha in the current study was.79. 
 
 Five Facet Mindfulness Questionnaire Short Form (FFMQ- SF) (Bohlmeijer 
et al, 2011) 
The FFMQ-SF is based on the original FFMQ which is a 39-item self-report measure 
that was developed by Baer and colleagues (2006) by integrating items from 
previous mindfulness measures (the MAAS, FMI, KIMS, CAMS and MQ) using a 
factor analytic approach and conducting an exploratory factor analysis (Baer et al, 
2006). It has been normed on undergraduate and community samples. The five 
factors are observing, describing, acting with awareness, non-judging of inner 
experience, and non-reactivity to inner experience. The five factors displayed 
adequate to good internal consistency and modest between factor analysis (Baer et al, 
2006). Further examination of the FFMQ was completed by Baer et al. (2008) and 
concluded that the five-factor model was satisfactorily reproduced with experienced 
meditators. In 2011, Bohlmeijer and colleagues published a shortened 24-item 
version of the FFMQ (FFMQ-SF). High correlations were demonstrated between the 
short form and the original FFMQ with the content validity and psychometric 
properties sufficiently preserved in the short form. The five-factor structure of the 
FFMQ-SF was further confirmed in a sample of fibromyalgia patients. Research has 
thus demonstrated that the FFMQ-SF is a reliable and valid measure for use in adults 
with clinically relevant symptoms of depression and anxiety. Cronbach’s alpha in the 
current study was.71. 
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3.5 Statistical Analysis 
Power Analysis 
An a priori power calculation was undertaken to estimate the desired sample size for 
this cross-sectional study. The statistical significance criterion was set at .05 and the 
power level was set at .8. It was anticipated that a maximum of 6 (catastrophising, 
mindfulness, depression, disease severity, perceived disability, age) variables would 
be used in any one regression analysis. An anticipated effect size was estimated by 
looking at previous similar cross-sectional research such as Cassidy and colleagues 
(2012) who investigated the relationship between mindfulness, disability, and 
psychological distress in a chronic pain population.  In the regression analysis, the 
smallest r2 value (.15) equates to a medium effect size. The estimated sample size for 
the current study according to the GPower Programme utilising linear multiple 
regression is 98.   
 
Previous research utilising postal questionnaire studies with COPD patients has 
demonstrated response rates of 75% (Sundha, Janson, Lisspersc, Ställbergc, & 
Montgomery, 2012, with  primary and secondary care patient sample), 63% (Hyland, 
Jones, & Hanney 2006, with a primary care and post-pulmonary rehabilitation 
sample) and 52% (Hoth, Wamboldt, Bowler, Make, & Holm, 2011, post hospital-
discharge sample). In light of the sample calculations and utilising the most 
conservative response rate estimates the current study aimed to recruit 188 people.   
However given that many of the COPD  population are older and there is a high 
proportion of dementias within Scotland (2.5% in people aged 30 + years and 7.2% 
in people aged 60 + years; Dementia Scotland, 2013) the current study utilising the 
highest percentage of estimated dementias aimed to invite 195 potential participants. 
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Description of analysis 
All research data was anonymised before being inputted into SPSS (version 19), 
which was used for all data analyses. Demographic and clinical characteristics were 
initially explored through descriptive statistics to characterize the sample.  
 
Key Hypotheses 
Pearson correlations and Spearman’s correlations were utilised to investigate the 
relationships amongst 1) the number of COPD-related hospital admissions and 2) 
anxiety and psychological distress (anxiety & depression), catastrophising, total 
mindfulness, disease severity, perceived disability and demographic factors. 
 
Multiple regressions were utilised to examine the predictive power of catastrophising 
and trait mindfulness in relation to anxiety and the frequency of COPD related 
hospital admissions when controlling for covariates e.g. patient demographics, illness 




















A total of 57 questionnaires were returned out of the 300 who were invited to 
participate in the research, with the study having a response rate of 19%. Of those 
who did not take part in the research, eight contacted the researcher to explain their 
reasons (; with one already involved in another study, one believed the questionnaire 
was too long and the remaining (n=6) did not give any reason). Of the returned 
questionnaires (n=57), 3 questionnaires were discounted as they were only partially 
completed.  The final sample was 54 people, 63% of whom were female with ages 
ranging from 41 – 86 years. A high proportion (78%) of this sample reported 
‘probable’ anxiety according to the HADS cut-off. The sample as a whole appeared 
to be physically quite unwell with the majority of the sample (74%) having severe or 
very severe COPD, a higher level of breathlessness and only 7% of the sample 
describing themselves as not having any other comorbidities. The average number of 
hospital admissions in the previous year was 2 admissions with a range of 0-11 
admissions. When asked about their current treatment regime, 74% of the sample 
reported using ongoing COPD treatment including nebuliser (43%) or long-term 
Oxygen treatment at home (4%) while a minority (5%) stated they were not on any 
ongoing COPD treatment. Nearly half of the sample lived on their own (42%) whist 
others lived with their partner (46%) or children (4%) and the others did not specify 
their living arrangements. The majority of the sample were retired (81%). (See Table 













Table 2.1: Demographic Characteristics of the Sample 
Variable  Response Level  N               % Mean (standard 
Deviation)  
Age                             Years                             54                               68 (9.8)  







34           63 
20           37 







10           19 
33           61 






Two admissions  
Three or more 
admissions  
12           22                             
12           22 
9             17 
21           39     
2 (2.3) (Range:0-11) 
Illness Severity  Mild                                           
                                    Moderate                                              
                                    Severe               
                                    Very severe 
Breathlessness         Grade 1 
Scale                          Grade 2 
                                    Grade 3 
                                    Grade 4 
                                    Grade 5 
Number of                 Zero 






6      11 
8       15 
37            68 
3                6 
0                0 
4                7 
12             22 
15             28 
23             43 
4                7 
12             22 
16             30 
11             20 
 5                9 
 3                6 
 3                6 
Smoking   Yes                                15              28 













IBPQ-S = Interpretation of Breathing Problems Questionnaire-Short Form, FFMQ-DE 
= Five Facet Mindfulness Questionnaire Describe, FFMQ-NR = Five Facet 
Mindfulness Questionnaire Non-react FFMQ-NJ= Five Facet Mindfulness 
Questionnaire Non-judge, FFMQ-OB= Five Facet Mindfulness Questionnaire 
Observe, FFMQ-AA= Five Facet Mindfulness Questionnaire Act aware, FFMQ-TOT= 
Five Facet Mindfulness Questionnaire Total, HADS-A = Hospital Anxiety & 
Depression Scale Anxiety, HADS-D= Hospital Anxiety & Depression Scale Depression 
 
 





































   
HADS-A 11 (4.9) 
 
 




Data Screening and Missing Data 
A Missing Data analysis indicated that data was missing at random and thus 
Expectation Maximisation was utilised to input missing data. Expectation 
Maximisation has been recommended as a reliable method for dealing with random 
missing data (Scholler, Bauman, & Card 2010). Data was checked for outliers and 
means, standard deviations and levels of skewness and kurtosis. All variables were 
found to be normally distributed except for the ‘Observe’ and ‘Non-judgemental’ 




Pearson correlations were utilised to explore the relationships between normally 
distributed variables while Spearman’s correlations were used for non-normally 




The number of COPD-related admissions to hospital over the past year will be 
negatively correlated with psychological distress (anxiety & depression), and 
mindfulness and positively correlated with catastrophising, disease severity and 
perceived disability (breathlessness). 
 
 
A statistically significant positive relationship existed between the number of COPD-
related hospital admissions and disease severity (r=.322, p<.01, N=54) and smoking 
(r=.240, p<.05, N=54). This indicated that a medium and small effect size were 
found for these hypothesis respectively, according to Cohen’s (1988) categorisation 
of effect sizes. When the various facets of mindfulness were explored in relation 
hospitalisation, the non-reactivity facet of mindfulness was significantly positively 
correlated with number of hospital admissions (r= .260, p≤. .05, N= 54), 
demonstrating a small effect size (See Table 2.3).  
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Table 2.3 Correlational Analyses for Key Variables 
Variable  Hospital Admissions                                               Anxiety                            
Age 
 
r = .023                           
p = .433                           
r = .-299  













Hospital Admissions  r =.218 
p = .057 
Illness Severity r=.322 
p=.009***          
r= .153 







Frequency of  





Smoking  r=.240       
p=.04*                                                   
r= -.176 
p= .101
Depression r= .140      
p=.156                                                    
r= .531 
p=.000***
Catastrophising r= .208         
p= .065                                               
r=.416 
p=.001*** 




























Anxiety will be positively correlated with catastrophising, depression, disease 




Anxiety scores were significantly positively correlated with breathlessness (r= .273, 
p<.05, N=54), depression (r= .531, p <.01, N=54), catastrophising r=.416, p≤.001, 
N=54) and negatively correlated with overall mindfulness (r = -.594, p≤.001, N=54) 
and age (r=.-299, p<.05, N=54). catastrophising 
When the various facets of mindfulness were explored in relation to anxiety acting 
with awareness (r= -.527, p≤.01, N=54), non-judgemental (r= -.527, p≤.01, N=54) 
and describe (r = -.499, p≤.01, N=54) facets of mindfulness were significantly 




















Catastrophising and trait mindfulness will be significant predictors of anxiety and 
frequency of COPD admissions to hospital when variance shared with confounding 
variables is controlled  
 
 
Multivariate analysis based on Hierarchical Regression was utilised to explore 
Hypothesis 3. Variables which were shown to be possible confounders in previous 
research and had shown significance in the previous bivariate analysis were inputted 
into the model. Due to the limited sample size in the current research, all possible 
predictor variables were not included. A p-value of ≤.05 was considered to be 
statistically significant. The data set was explored to ensure it fulfilled the necessary 
assumptions related to multicollinearity, outliers, homoscedasticity and independence 
of residuals. The data did not break any of these assumptions and thus two regression 
models were created.   
 
 
In the first Hierarchical Regression Model, Smoking and COPD severity, which were 
found to be significantly related to hospitalisations in the initial correlation analysis 
were inputted in the first step of the model as they were probable confounders. 
Catastrophising and Total Mindfulness were then inputted in the second stage of the 
model (See Table 2.4). The model as a whole predicted 16.3% of the variance in 










Table 2.4 Hierarchical Regression for Predicting Hospitalisations 
 










































In the second Hierarchical Regression  Model, Age, Breathlessness and Depression, 
which were found to be significantly related to anxiety in the initial correlation 
analysis were inputted in the first step of the model as they were probable 
confounders. Catastrophising and Total Mindfulness were then inputted in the second 
stage of the model (See Table 2.6). The model as a whole predicts 52.9% of the 
variance in anxiety in those with COPD, with an additional 22.3% of this variance 
explained by Catastrophising and Overall Mindfulness. The model as a whole is 







Table 2.5 Hierarchical Regression for Predicting Anxiety 
 































































The current study had two main aims. The first aim was to explore what 
psychological, illness-specific and demographic factors were associated with anxiety 
in COPD and whether catastrophising or mindfulness demonstrated any unique 
variance in predicting anxiety. The second aim was to explore what factors were 
associated with COPD hospital admissions and whether catastrophising or 
mindfulness demonstrated any unique variance in predicting hospitalisation. 
 
 
In order to understand the study’s findings, it is important to consider them in view 
of the sample study. The current sample was mostly representative of the COPD 
population with an almost equal mix in gender and a good age-range which has been 
noted as a limitation in previous studies (O’Brien & Morris, 2014). The majority of 
the current study reported more severe disease, a high rate of comorbidities and 
increased   perceived breathlessness. It is therefore less likely that the findings from 
this study will be representative of those who are in the earlier stages of their COPD 
illness. There was a high prevalence of probable anxiety (78%) reported in the 
sample which is generally higher than the prevalence reported in previous studies 
(e.g. 41%, Gudmundsson et al, 2005). The scores on the measures of catastrophising, 
anxiety and depression were similar to those reported by Livermore et al (2012) in 
their research into panic in COPD and the scores for mindfulness were similar to 
those reported by Bohlmeijer et al (2011) in a sample with clinically relevant 
symptoms of depression and anxiety pre-therapeutic intervention. 
 
 
In this study increased anxiety was statistically significantly related to increased 
breathlessness, catastrophising and depression. This is in line with previous research 
(Di Marco, Verga & Reggente, 2006; Kunik et al, 2005; Livermore et al, 2012). 
These findings in relation to anxiety support the cognitive model of anxiety (Clark, 
1986), whereby internal sensations such as breathlessness can be misinterpreted as 
dangerous and result in an individual catastrophising and an increase in anxiety. 
Furthermore, increased anxiety was strongly correlated with reduced overall 
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mindfulness and specifically with reduced ’awareness’, ‘non-judgemental’ and 
‘describe’ facets. This is in line with previous research by Baer et al (2008) who 
suggest these facets are associated with fewer symptoms and lower anxiety. In the 
statistically significant hierarchical regression model for predicting anxiety, 
catastrophising and mindfulness predicted 22.3% of the variance in the model. These 
constructs have little or no research  in COPD and our findings suggest they are 
worth further investigation.  
 
 
In this study increased  hospitalisation was significantly related to disease severity 
and smoking which again is inline with previous research (Godtfredsen et al, 2002; 
Wedzicha et al, 2007). Although not statistically significantly related to increased 
hospitalisations, catastrophising, anxiety and worse breathlessness exhibited a clear 
association. Catastrophising and mindfulness predicted 16.3% of the variance in 
hospitalisations.  The ‘non-reactivity’ facet of mindfulness was positively related to 
hospitalisations, which is the opposite of what one might expect (Baer et al, 2008). In 
their study, Consedine & Butler, (2013) stated that ‘non-reactivity’ predicted less 
psychological appointments.  However their sample were young healthy adults and 
the method of healthcare use monitoring was retrospective self-report of the past 
year, which may have resulted in a bias. Furthermore, in the current sample of those 
with COPD, being reactive to symptoms may act as a protective  and sensible coping 
style, which may increase an individual’s attention upon their symptoms thus 
resulting in increased  hospital utilisation.  Mindfulness scales have been criticised as 
the understanding of some scale items seem dependant on personal mindfulness 
practice (Grossman, 2008) and he further posits that there may be a significant 
difference between how mindful someone believes they are and how truly mindful 
they are.  
 
 
The current sample of COPD patients demonstrated a high level of anxiety. Research 
has demonstrated that those who experience anxiety/depression are less likely to 
engage in self-management programmes e.g. pulmonary rehabilitation (Cassidy, 
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Turnball, Gardani & Kirkwood, 2012). Guidelines for COPD  (NICE, 2010)  
recommend screening for distress. Coventry et al (2013) in a systematic review and 
meta-analysis demonstrated some evidence for the effectiveness of psychological and 
lifestyle interventions in reducing anxiety in those with COPD. A recent meta-
analysis of mindfulness interventions for various psychological and medical 
conditions demonstrated a reduction in anxiety and mood symptoms (Hofman, 
Sawyer, Witt & Oh, 2010). Future intervention  trials should be utilised to explore 
the effectiveness of interventions that included catastrophising and/or mindfulness on 
anxiety levels and hospitalisations in COPD. 
   
 
As far as the author is aware, this is the first study to explore the role of 
catastophising and mindfulness in relation to hospitalisations in COPD. From this 
study, it is clear that these cognitive factors may play a role in how people 
understand their illness experience and seek help from hospitals, even when 
controlling for other covariates. A clear strength of the current study is that 
information about healthcare use was gathered from hospital records. However only 
hospital admissions and not emergency room admissions or primary care use were 
recorded.  A further strength is that a number of possible covariates were included in 
the analyses to try to understand the variance that the cognitive factors under study 
uniquely explained. However, in this study people were not asked about previous or 
ongoing pulmonary rehabilitation or community team involvement which may have 
impacted upon their hospital use. Evidence has demonstrated that pulmonary 
rehabilitation has a positive impact upon psychological distress (Coventry & Hind, 
2007).  The response rate of the current study was poor and thus may impact upon 
the representativeness of the sample. The current study is cross-sectional 
retrospective in design and thus we could not explore any causal relationships 
between the variables.  
 
 
Identifying and improving the health of patients with COPD and preventing 
unnecessary hospitalisations is a key objective of healthcare professionals. This is the 
70 
 
first study to  investigate overall mindfulness and the facets of mindfulness which 
specifically impact upon anxiety and hospital utilisation in those with COPD. The 
findings from this study should be treated with some caution due to the exploratory 
nature of this research. The conclusions warrant further scrutiny from well designed 
prospective studies to investigate these factors with a larger sample to ensure 
sufficient power and the avoidance of a Type II error.  
 
 
The current study demonstrated that a high proportion of  those who are hospitalised 
with COPD experienced anxiety for which higher catastrophising and lower 
mindfulness was a significant predictor. These findings suggest that it is important 
for healthcare professionals to assess psychological factors which may impact upon 
healthcare utilisation. Introducing psychological screening  to the COPD care 
pathway could aid earlier detection of  psychological distress and thus enable referral 
to appropriate services.  Interventions focused upon these psychological factors may 
have an important impact upon a patient’s health care experience, their healthcare 
utilisation and upon the economic costs of COPD patients.  Coventry et al (2013)  
suggest that there is some evidence for the effectiveness of psychological 
interventions for reducing anxiety in those with COPD. Further research studies  
utilising a psychological intervention based upon catastrophising and/or  mindfulness 
and  it’s impact upon anxiety and hospitalisations could increase our knowledge 
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Chapter 3: Additional Methodology Chapter 
This chapter will describe in greater detail the methodological procedures undertaken 
in the current research study. It will be divided into two subheadings: 1) Ethical 
issues and approval and 2) Measures. 
 
3. 1 Ethical Issues & Approval 
Ethical Approval 
The research proposal was initially reviewed by a member of the Doctorate in 
Clinical Psychology Team. Feedback from this review was then incorporated into the 
research proposal.  NHS ethical approval for the research study was then obtained 
from the South East Scotland Research Ethics Committee. 
 
Consenting Process 
The participant information sheet (See Appendix E) gave detailed information about 
the current study including information about confidentiality and consent. The 
participant information sheet emphasised that participants could leave the study at 
any time and that this would not have any impact on any treatment they received. If a 
potential participant was interested in taking part in the current research study, they 
were asked to complete and sign the consent form (See appendix F). Participants 
were asked to give permission for anonymised research data to be stored and/or 
examined by NHS Lothian and regulatory authorities for monitoring purposes and 
for their anonymised data to be used in future research project if of public interest. 








The recommendations of the NHS Code of Practice on Protecting Patient 
Confidentiality (Scottish Executive, 2003) and the Code of Human Research Ethics 
(British Psychological Society, 2010) informed the current procedure.  
 
Data about potential participants (e.g. name, contact details and number of COPD 
related hospital admissions) was initially gathered by a data manager within NHS 
Lothian. The list of potential participants was given to a member of the respiratory 
team who was already a part of their direct clinical care team. They sent out the 
questionnaire pack to the selected potential participants. No personal information 
about potential participants was given to the Chief Investigator prior to consent being 
obtained from the participants themselves. 
 
Participants’ names and signature appeared on the paper consent forms. A study 
number was utilised on the questionnaire pack to allow the researcher to link the 
consent form with the questionnaire pack so that the data could be located if a 
participant decided to withdraw from the study.  The consent form was separated 
from the rest of the questionnaire pack. Consent forms and completed questionnaire 
packs were stored separately in a locked filing cabinet on NHS premises.  
 
All identifying information was removed from the research data when it was 
transferred to a statistical package for analysis to ensure confidentiality. Furthermore 







3. 2 Measures 
Readability 
COPD is more prevalent in older adults and in lower socio-economic groups where 
low levels of literacy are common (Jahagirdar et al, 2013; Wolf et al, 2005). A 
British outpatient study of COPD patients demonstrated that 15% of patients were 
not able to use written information (Taylor et al 2005). Roberts and colleagues 
(2008) recommend that written materials for those with COPD should be tested for 
levels of readability to ensure accessibility. A readability assessment, of the current 
questionnaires indicated Flesch Reading Ease (FRE) scores of between 85.9 and 60.7 
i.e. ranging from an ‘easy’ to ‘standard’ readability level. The higher the FRE score 
the easier the document is to read.  The Scottish Executive (2006) recommends that 
most standard documents should aim for a score of approximately 60 to 70. The 
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separately.  
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British Journal of Health Psychology is covered by the Early View service on Wiley 
Online Library. Early View articles are complete full-text articles published online in 
advance of their publication in a printed issue. Articles are therefore available as 
soon as they are ready, rather than having to wait for the next scheduled print issue. 
Early View articles are complete and final. They have been fully reviewed, revised 
and edited for publication, and the authors’ final corrections have been incorporated. 
Because they are in final form, no changes can be made after online publication. The 
nature of Early View articles means that they do not yet have volume, issue or page 
numbers, so they cannot be cited in the traditional way. They are cited using their 
Digital Object Identifier (DOI) with no volume and issue or pagination information. 
Eg Jones, A.B. (2010). Human rights Issues. Journal of Human Rights. Advance 
online publication. doi:10.1111/j.1467-9299.2010.00300.x  
Further information about the process of peer review and production can be found in 












Studies excluded (N) Reason(s) for exclusion 
Abstract Review 
 
5 studies excluded  Qualitative Research 
22 studies excluded Anxiety not measured 
46 studies excluded Hospitalisation not measured 
15 studies excluded 
 
Review article, descriptive article or 
book chapter 
3 studies excluded Conference presentation/poster  
2 studies excluded 
 
Wrong population (disease/caregiver 
research) 
Full article Review 
 
1 study excluded 
 
Qualitative Research 
12 studies excluded Anxiety not measured/not differentiated 
from depression  
5 studies excluded 
 
Hospitalisation not measured 
13 studies excluded 
 
Association between anxiety and 
hospitalisation not measured 
5 studies excluded 
 
Review article, descriptive article or 
book chapter 
2 studies excluded 
 
Conference presentation/poster  
1 study excluded 
 
Case study 
1 study excluded 
 
Not available in English language 
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Appendix C: Study Rating Scale 
 
Quality criteria 
Title: Does anxiety impact upon COPD hospital admissions? 
AUTHORS: Gráinne O’ Brien 
(Supervisor – Paul Graham Morris) 
TITLE of study being reviewed: 
Authors of study being reviewed: 
1. Sample (representativeness) 
1.1: How 
approached? 
The sampling method 
ensures that the 
sample selected is 
representative of the 
COPD population 
and is thus 
generalizable 
Well covered... 2 
Adequately addressed... 
1 
Poorly addressed... 0 
Not addressed (i.e. not 
mentioned, or indicates 
that this aspect of study 
design was ignored)...0 
Not reported (i.e. 
mentioned but 
insufficient detail to 
allow assessment to be 
made)...0 
Not applicable...0 
Well covered= the sampling method 
is clearly reported and ensures that 
minimal bias is introduced (e.g. 
random sequence of those admitted 
to hospital). Appropriate 
inclusion/exclusion criteria are 
applied.  
Adequately addressed= the 
sampling method may introduce an 
element of bias. Inclusion/Exclusion 
criteria inappropriate. 
Poorly addressed = Inclusion/ 













Well covered... 2 
Adequately addressed 
... 1 
Poorly addressed... 0 
Not reported...0 
 
Well covered = Relevant 
demographic and clinical 
characteristics are described 
(Severity of COPD, age, gender) 
and are representative of population 
Adequately addressed = At least two 
relevant patient characteristics are 
described (Severity of COPD, age, 
gender) and are representative of 
population 
Poorly addressed = One or no 
relevant patient characteristics are 
described (Severity of COPD, age, 
gender) or are  
not representative of population 
1.3: Who 
took part? 
The study clearly 
indicates number of 
participants invited to 
take part in research 
and states 
attrition/questionnaire 
Well covered... 2 
Adequately addressed 
... 1 
Poorly addressed... 0 
Not addressed...0 
Not reported...0 
Well covered = details given 
regarding numbers of people invited 
participate in study, opt in rate and 
drop out rate 
Adequately addressed = details 
given on at least two of the 
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return rates  following: number of people invited 
to participate in study, opt in rate, 
drop out rate  
Poorly addressed = insufficient 
detail given i.e. detail given on less 
than two of the following: number 
of people invited to participate in 
study, opt in rate, drop out rate 
 
                                                                                                                                                 /6 
2. Power & Sample Size 
2.1 Sample size was 
sufficient for analysis 
relating to anxiety & 
hospitalisation 
Well covered... 2 
Adequately addressed ... 
1 




Well covered= Number of participants was 
sufficient to enable power of at least .8, 
where effect size was medium and alpha 
was set at .05 
Adequately addressed= Number of 
participants was sufficient to enable power 
of at least .7, where effect size was medium 
and alpha was set at .05 
Poorly addressed = Number of participants 
was sufficient to enable power of less than 
.7, where effect size was medium and alpha 
was set at.05 
 
                                                                                                                                                   /2 
3. Outcome measures 
3.1 Anxiety is measured 
in a standard, valid, 
reliable way 
Well covered... 2 
Adequately addressed... 1 
Poorly addressed... 0 
Not reported...0 
 
Well covered= Anxiety measure is a 
diagnostic measure  
Adequately addressed= Anxiety measure is 
a screening measure and has acceptable 
validity/psychometrics and  valid for those 
with COPD 
Poorly addressed = Anxiety measures do 
not have acceptable validity/ psychometrics 









Well covered... 2 
Adequately addressed ... 
1 
Poorly addressed... 0 
Not reported...0 
 
Well covered = Measured through a 
Hospital or Community Database or  A&E 
records  
Adequately addressed = Measured through 
patient self-report  
Poorly addressed = Unclear how measured. 
 
                                                                                                                                                       /4 
4. Statistical Analysis 
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4.1 Data analysis is 
appropriate to the 
study design and the 
type of outcome 
measure. 
Well covered... 2 
Poorly addressed... 0 
Not reported...0 
 
Well covered = analysis appropriate to 
design.  
Poorly addressed=Inappropriate analysis 
used. Poor method used to deal with 








addressed in study. 
Well covered... 2 
Adequately addressed ... 
1 
Poorly addressed... 0 
Not reported...0 
 
Well covered = Potential confounding 
variables are adequately recognised and 
considered in the statistical analysis 
Adequately addressed= Potential 
confounding variables are recognised  but 
are not considered in the statistical analysis 
Poorly addressed= Potential confounding 
variables are not recognised or considered 
in the statistical analysis 
                                                                                                                                                 /4 
























* FEV1/FVC < 0.7  
* FEV1 > or = 80% predicted  
At this stage, the patient is 
probably unaware that lung 
function is starting to decline 
II. Moderate 
COPD  
* FEV1/FVC < 0.7  
* FEV1 50% to 79% 
predicted 
Symptoms during this stage 
progress, with shortness of breath 
developing upon exertion. 
III. Severe 
COPD 
* FEV1/FVC < 0.7  
* FEV1 30% to 49% 
predicted  
Shortness of breath becomes 
worse at this stage and COPD 




* FEV1/FVC < 0.7  
* FEV1 < 30% predicted or 
FEV1 < 50% predicted with 
chronic respiratory failure  
Quality of life at this stage is 
gravely impaired. COPD 
















Appendix E  -Information Sheet 
Do psychological factors impact on anxiety and COPD related hospital 
admissions? 
 
We would like to invite you to take part in a research study about living with 
COPD. Before you decide if you would like to take part, you need to 
understand why the research is being done and what it would involve for you. 
Please take time to read the following information carefully.  
 
Ask us if there is anything that is not clear or if you would like more 
information. Take time to decide whether or not you wish to take part in the 
research.  
   
What is the purpose of the study? 
We know that living with COPD can be very challenging for people. The 
symptoms can affect what you can and cannot do, and we know it can affect 
how people feel. This research study asks you questions about how COPD 
affects activities, moods and feelings as well as your thoughts about living 
with COPD. We hope that the results from this study will help us to 
understand more about the challenges of living with COPD. This will help us 
to think about possible supports that health professionals may be able to put 
in place to help people with COPD. 
 
Why have I been invited? 
People who have COPD and who have had at least one COPD-related 
hospital admission in the past three years have been invited to take part in 
this research study. 
 
What will I have to do? 
If you are interested in taking part in this research, please read the rest of this 
information sheet and then complete the attached consent form and 
questionnaire booklet. It contains questions about yourself and your 
experience of living with the symptoms of COPD. This may take up to 30 
minutes to complete. Please use the attached stamped addressed envelope 
to return it to the researcher. We would be grateful if you could return this 
questionnaire within two weeks. 
 
As the study involves recording medical information about your COPD and 
previous hospital admissions, we would like to seek your permission to 
access your medical records. If you are happy for us to do this, there is a box 
for you to tick on the consent form. All the information collected will be kept in 
the strictest of confidence by the study investigators.  
 
Completing the questionnaire pack may highlight if you are experiencing any 
difficult emotions presently e.g. being afraid or feeling down about your 
COPD. We encourage you to contact your GP to discuss this as there may 
be services that may be helpful for you. Alternatively, a helpful free website is 
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http://www.llttf.com. This website ‘living Life to the Full’ is a free online life 
skills course with advice about anxiety and low mood. 
 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you decide not to take 
part in this research, it will not affect any care or treatment you receive. If you 
decide to take part you are still free to withdraw at any time and without 
giving a reason.  
 
What are the possible disadvantages and risks of taking part? 
It will take a little time to complete the questionnaire pack. Do not feel like 
you have to do this in one sitting, you can take your time and if it is easier 
you can complete the booklet over a number of shorter sittings (e.g. chunk it 
in to 5-10 minute slots spread over the day). If you would like some support 
to complete this questionnaire, please ring the number 0131 537 9139 or 
email grainne.o’brien@nhslothian.scot.nhs.uk and we can complete it over 
the telephone once your consent form has been returned.  
 
What are the possible benefits of taking part? 
We hope that the results from this study will help us to understand more 
about the challenges for people of living with COPD. The research will further 
help us to understand if there are certain important factors when living with 
COPD that can lead to emotional distress or increased hospital admissions 
for people. The project may highlight possible suggestions of supports or 
psychological therapies that may be useful for people with COPD.  
 
Will my taking part in the study be kept confidential? 
We will write up the results from the study and share this information with 
staff working with people with COPD. This will probably be in a specialist 
medical journal. All identifiable information will be removed prior to the write-
up stage of the research process and your personal information will not 
appear in any report.  
 
If you agree to take part in this study, your GP will be informed of your 
participation and of any outcomes. 
 
According to Scottish regulations related to research, it is recommended that 
data be available to Sponsor(s) from regulatory authorities or NHS Lothian so 
they can monitor research standards. In the consent form, we seek your 
permission for this. Furthermore, we seek your permission to store your 
anonymised data so that it may be used in future research projects if of 
public interest. 
 
What happens when the research stops? 
At the end of the research you will receive information about the results of the 





I have more questions…….. 
If you have any questions about the project please contact: 
 
Gráinne O’ Brien 
Chief Investigator 
Department of Clinical Psychology, Astley Ainslie Hospital, Edinburgh 
Tel: 0131 537 9139 
Email: grainne.o’brien@nhslothian.scot.nhs.uk 
 
Alternatively, you can contact somebody independent of the research team 
Dr Evelyn Janetta 
Clinical Psychologist 
Department of Clinical Psychology, Astley Ainslie Hospital, Edinburgh 




If you wish to make a complaint about the study please contact NHS Lothian: 
 
NHS Lothian Complaints Team 
2nd Floor 
Waverley Gate 
2-4 Waterloo Place 
Edinburgh 
EH1 3EG 

















Appendix F: Consent Form 
CONSENT FORM 
Patient Identification Number :  Chief Investigator: Gráinne O’ Brien 
Project: Do psychological factors impact on anxiety and COPD related hospital 
admissions?    
Please read the below statements and put your initials in the box if you are in 
agreement              Please put your       
                                                                                                     initials in the box  
1.  I confirm that I have read and understand the information sheet dated 
 17/4/13 (V4) for the above study. I have had the opportunity to consider 
  the information, ask questions and have had these answered satisfactorily.  
 
 
2.    I understand that my participation is voluntary and I am free to withdraw 
       at any time without giving any reason, without my medical care or legal 
       rights being affected.  
 
 
3    I understand that relevant sections of my medical notes and data collected 
during the study may be looked at by individuals from the Research team, 
Sponsor(s), from regulatory authorities or from the NHS Board where it is 
relevant to my taking part in this research. I give permission for those 
individuals to have access to my records  
              
4.   I give permission for my anonymised data to be used in future research 
projects 
      if of public interest. 
 
5.   I understand that my GP will be notified that I am taking part in this 
research and will be updated on any outcomes. 
6.    I would like to receive feedback from this research study. 
_____________________ ________________  __________________________  
Signature  (Participant)      Date                                  Name (Participant) 
 
_____________________ ________________  __________________________  
Signature                                  Date                        Name  
(Person taking consent)                                                  (Person taking 
consent)  
       
 
 
 
 
 
 
